1,2,3,4-tetrahydroisoquinoline has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Härkönen, P; Hedblom, A; Johansson, ME; Larsson, R; Miftakhova, RR; Persson, JL; Sarwar, M; Semenas, J; Shcherbina, L; Sterner, O | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Invasiveness, Neoplasm
Article | Year |
---|---|
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Diketopiperazines; Disease Models, Animal; Drug Discovery; Humans; Indoles; Isoquinolines; Male; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetrahydroisoquinolines; Xenograft Model Antitumor Assays | 2014 |